Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
(Bloomberg) -- Pfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez, gained clearance for patients with hemophilia B, a rare bleeding …